UNIIQ

Buddy Payment B.V. is a company based in Rotterdam, the Netherlands, that has developed an internet banking application known as Buddy. Founded in 2018, this application assists users in managing their finances by providing insights into their income and expenditures. It enables users to send inquiries regarding bills, surcharges, or benefits, thereby facilitating better understanding and control over their financial obligations. Additionally, Buddy offers advice on managing cash flow, helping users to set aside fixed costs and providing tips to save on purchases. Through these features, Buddy Payment aims to prevent debt and improve users' overall financial well-being.

Captain AI develops an autonomous shipping solution using high-fidelity simulation, sensors, and state-of-the-art deep learning techniques. Founded in 2018, Captain AI is headquartered in Rotterdam.

Focus is a legal tech startup that developed an algorithm that can rank patents based on their technological importance. They combine knowledge of the patent industry with a model-based, econometrical outlook to develop a superior and unique ranking algorithm. This algorithm has proven itself within a select number of technical domains during tests with potential customers. Focus was founded in 2019 and is based in Rotterdam, Zuid-Holland, The Netherlands.

Clockworks is an AI platform that provides machine learning and artificial intelligence solutions. They intended to build a shared passion for the possibilities of data and data-driven innovation. They identify the potential of big data and develop data science as a service for actionable insights, enabling customers to read all water, gas, and electricity meters with the camera of their mobile phones.

Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in developing advanced thermotherapy systems for treating head and neck cancers. The company's proprietary technology incorporates localized heating through an integrated microwave system, complemented by interactive software, which allows healthcare professionals to enhance traditional cancer treatments such as radiotherapy and chemotherapy. This innovative approach aims to improve patient outcomes and quality of life by mitigating the toxic effects commonly associated with standard therapies. Sensius has successfully treated seventy patients with its device, achieving a complete response rate of 81.8% at 12 weeks post-treatment. Currently, the company is working towards obtaining CE marking for its device, with significant interest from potential buyers, as it also plans to expand its application to other cancer types in the future.